Monoclonal Antibodies Market for Breast Cancer to More than Double by 2019 PR Carbon (press release) FOR IMMEDIATE RELEASE, Illinois – United States – November 06, 2013 (PR Carbon): The market value for monoclonal antibodies (mAbs) in breast cancer treatment will experience a massive increase from $4.8 billion in 2012 to $10.9 billion in 2019, ... |
